Thank you for all you do, Reed's
Retatrutide Clinical Studies Registry
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful weight loss while simultaneously protecting the heart, kidneys, and metabolic health
The app is genuinely impressive: AI-powered personalization through Welli, one-on-one behavior coaching, personal meal plans, fitness tools with Muscle Defense, and a supportive community
GLP-1RAs have been shown to improve diabetes, promote weight loss, and reduce hepatic fat content (Yao et al., 2024)
Published data from cagrilintide research specifically demonstrates reductions in relative fat mass while maintaining relative lean mass